Erratum: The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series (PLoS Negl Trop Dis (2018) 12: 2 (e0006212) DOI: 10.1371/journal.pntd.0006212);The spectrum of neurological disease associated with Zika and chikungunya viruses in adults in Rio de Janeiro, Brazil: A case series

PLoS Neglected Tropical Diseases

Volumn 12, Issue 2, 2018, Pages

  Mehta, Ravi ^a   Soares, Cristiane Nascimento ^b   Medialdea Carrera, Raquel ^a   Ellul, Mark ^a,c   da Silva, Marcus Tulius Texeira ^d,e   Rosala Hallas, Anna ^a   Jardim, Marcia Rodrigues ^f   Burnside, Girvan ^a   Pamplona, Luciana ^g   Bhojak, Maneesh ^c   Manohar, Radhika ^c   da Silva, Gabriel Amorelli Medeiros ^b   Adriano, Marcus Vinicius ^h   Brasil, Patricia ^d   Nogueira, Rita Maria Ribeiro ⁱ   Dos Santos, Carolina Cardoso ⁱ   Turtle, Lance ^a,c   de Sequeira, Patricia Carvalho ⁱ   Brown, David W ^i,j   Griffiths, Michael J ^a,k   de Filippis, Ana Maria Bispo ⁱ   Solomon, Tom ^a,c   more..

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Hospital Federal dos Servidores do Estado   (Brazil)

^c THE WALTON CENTRE NHS FOUNDATION TRUST   (United Kingdom)

^d Funda??o Oswaldo Cruz   (Brazil)

^e Hospital de Clinicas de Niteroi   (Brazil)

^f HOSPITAL UNIVERSITÁRIO PEDRO ERNESTO   (Brazil)

^g HOSPITAL GERAL DE BONSUCESSO   (Brazil)

^h Hospital Barra D'Or   (Brazil)

ⁱ INSTITUTO OSWALDO CRUZ   (Brazil)

^j PUBLIC HEALTH ENGLAND   (United Kingdom)

^k ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CEREBROSPINAL FLUID ANALYSIS; CHIKUNGUNYA VIRUS; CLINICAL ARTICLE; CLINICAL FEATURE; CROSS REACTION; DENGUE VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FACIAL NERVE PARALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; MENINGOENCEPHALITIS; MYELITIS; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PARESTHESIA; POLYMERASE CHAIN REACTION; RADICULITIS; SEROLOGY; VERY ELDERLY; VIROLOGY; ZIKA VIRUS; CEREBROSPINAL FLUID; CHIKUNGUNYA; COMPLICATION; DENGUE; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; YOUNG ADULT; ZIKA FEVER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAZIL; CEREBROSPINAL FLUID; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; DENGUE; DENGUE VIRUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85044395544     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0007166     Document Type: Erratum

References (40)

1. Musso D, Gubler DJ, Zika Virus. Clin Microbiol Rev. 2016;29(3):487–524. doi: 10.1128/CMR.00072-15 27029595
2. Brazilian Ministry of Health. Protocolo de vigilância e resposta à ocorrência de microcefalia 2016 [Available from: http://portalsaude.saude.gov.br/images/pdf/2016/janeiro/22/microcefalia-protocolo-de-vigilancia-e-resposta-v1-3-22jan2016.pdf.
3. Arias A, Torres-Tobar L, Hernandez G, Paipilla D, Palacios E, Torres Y, et al. Guillain-Barre syndrome in patients with a recent history of Zika in Cucuta, Colombia: A descriptive case series of 19 patients from December 2015 to March 2016. J Crit Care. 2017;37:19–23. doi: 10.1016/j.jcrc.2016.08.016 27610587
4. Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, et al. Guillain-Barre Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027):1531–9. doi: 10.1016/S0140-6736(16)00562-6 26948433
5. Parra B, Lizarazo J, Jimenez-Arango JA, Zea-Vera AF, Gonzalez-Manrique G, Vargas J, et al. Guillain-Barre Syndrome Associated with Zika Virus Infection in Colombia. N Engl J Med. 2016;375:1513–23. doi: 10.1056/NEJMoa1605564 27705091
6. Malta JMAS, Vargas A, Leite PLe, Percio J, Coelho GE, Ferraro AHA, et al. Síndrome de Guillain-Barré e outras manifestações neurológicas possivelmente relacionadas à infecção pelo vírus Zika em municípios da Bahia, 2015. Epidemiologia e Serviços de Saúde. 2017;26:9–18. doi: 10.5123/S1679-49742017000100002 28226004
7. World Health Organisation. Fifth meeting of the Emergency Committee under the International Health Regulations (2005) regarding microcephaly, other neurological disorders and Zika virus 2016 [Available from: http://www.who.int/mediacentre/news/statements/2016/zika-fifth-ec/en/.
8. Smith DW, Mackenzie J, Zika virus and Guillain-Barre syndrome: another viral cause to add to the list. Lancet. 2016;387(10027):1486–8. doi: 10.1016/S0140-6736(16)00564-X 26948432
9. Solomon T, Kneen R, Dung NM, Khanh VC, Thuy TT, Ha DQ, et al. Poliomyelitis-like illness due to Japanese encephalitis virus. Lancet. 1998;351(9109):1094–7. doi: 10.1016/S0140-6736(97)07509-0 9660579
10. Mecharles S, Herrmann C, Poullain P, Tran TH, Deschamps N, Mathon G, et al. Acute myelitis due to Zika virus infection. Lancet. 2016;387(10026):1481. doi: 10.1016/S0140-6736(16)00644-9 26946926
11. Roze B, Najioullah F, Signate A, Apetse K, Brouste Y, Gourgoudou S, et al. Zika virus detection in cerebrospinal fluid from two patients with encephalopathy, Martinique, February 2016. Euro Surveill. 2016;21(16).
12. Soares CN, Brasil P, Carrera RM, Sequeira P, de Filippis AB, Borges VA, et al. Fatal encephalitis associated with Zika virus infection in an adult. J Clin Virol. 2016;83:63–5. doi: 10.1016/j.jcv.2016.08.297 27598870
13. Carteaux G, Maquart M, Bedet A, Contou D, Brugieres P, Fourati S, et al. Zika Virus Associated with Meningoencephalitis. N Engl J Med. 2016;374(16):1595–6. doi: 10.1056/NEJMc1602964 26958738
14. Niemeyer B, Niemeyer R, Borges R, Marchiori E, Acute Disseminated Encephalomyelitis Following Zika Virus Infection. European neurology. 2017;77(1–2):45–6. doi: 10.1159/000453396 27894121
15. Kassavetis P, Joseph JM, Francois R, Perloff MD, Berkowitz AL, Zika virus-associated Guillain-Barre syndrome variant in Haiti. Neurology. 2016;87(3):336–7. doi: 10.1212/WNL.0000000000002759 27164708
16. Molko N, Simon O, Guyon D, Biron A, Dupont-Rouzeyrol M, Gourinat AC, Zika virus infection and myasthenia gravis: Report of 2 cases. Neurology. 2017.
17. Bureau de la Veille Sanitaire de la Direction de la Santé Publique. Surveillance de la dengue et du zika en Polynésie française 2014 [Available from: http://www.hygiene-publique.gov.pf/spip.php?article120.
18. Weaver SC, Lecuit M, Chikungunya virus and the global spread of a mosquito-borne disease. N Engl J Med. 2015;372(13):1231–9. doi: 10.1056/NEJMra1406035 25806915
19. Pan American Health Organisation. Chikungunya: Statistic Data 2016 [Available from: http://www.paho.org/hq/index.php?option=com_topics&view=article&id=343&Itemid=40931.
20. Arpino C, Curatolo P, Rezza G, Chikungunya and the nervous system: what we do and do not know. Rev Med Virol. 2009;19(3):121–9. doi: 10.1002/rmv.606 19274635
21. Martins HAL, Bernardino SN, Ribas KH, Santos CC, Antunes T, Outbreak of Neuro-Chikungunya in Northeastern Brazil. Journal of Neuroinfectious Diseases. 2016;7(2).
22. Solomon T, Dung NM, Vaughn DW, Kneen R, Thao LT, Raengsakulrach B, et al. Neurological manifestations of dengue infection. Lancet. 2000;355(9209):1053–9. doi: 10.1016/S0140-6736(00)02036-5 10744091
23. World Health Organisation. Laboratory testing for Zika virus infection—interim guidance 2016 [Available from: http://www.who.int/csr/resources/publications/zika/laboratory-testing/en/.
24. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8):1232–9. doi: 10.3201/eid1408.080287 18680646
25. Steinhagen K, Probst C, Radzimski C, Schmidt-Chanasit J, Emmerich P, van Esbroeck M, et al. Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill. 2016;21(50).
26. Huzly D, Hanselmann I, Schmidt-Chanasit J, Panning M, High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill. 2016;21(16).
27. Prat CM, Flusin O, Panella A, Tenebray B, Lanciotti R, Leparc-Goffart I, Evaluation of commercially available serologic diagnostic tests for chikungunya virus. Emerg Infect Dis. 2014;20(12):2129–32. doi: 10.3201/eid2012.141269 25418184
28. Centers for Disease Control and Prevention. Zika MAC-ELISA Instructions for Use 2016 [Available from: http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM488044.pdf.
29. World Health Organisation. Situation Report—Zika Virus, Microcephaly, Guillain-Barré Syndrome 2016 [Available from: http://www.who.int/emergencies/zika-virus/situation-report/en/.
30. Acevedo N, Waggoner J, Rodriguez M, Rivera L, Landivar J, Pinsky B, et al. Zika Virus, Chikungunya Virus, and Dengue Virus in Cerebrospinal Fluid from Adults with Neurological Manifestations, Guayaquil, Ecuador. Frontiers in microbiology. 2017;8:42. doi: 10.3389/fmicb.2017.00042 28174559
31. Solomon T, Flavivirus encephalitis. N Engl J Med. 2004;351(4):370–8. doi: 10.1056/NEJMra030476 15269317
32. Wakerley BR, Uncini A, Yuki N, Group GBSC, Group GBSC. Guillain-Barre and Miller Fisher syndromes—new diagnostic classification. Nature reviews Neurology. 2014;10(9):537–44. doi: 10.1038/nrneurol.2014.138 25072194
33. Brazilian Ministry of Health. Epidemiological Bulletin 2017 [Available from: http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/leia-mais-o-ministerio/197-secretaria-svs/11955-boletins-epidemiologicos-arquivos.
34. Teixeira MG, Costa Mda C, Barreto F, Barreto ML, Dengue: twenty-five years since reemergence in Brazil. Cad Saude Publica. 2009;25Suppl 1:S7–18.
35. Guzman MG, Alvarez M, Halstead SB, Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol. 2013;158(7):1445–59. doi: 10.1007/s00705-013-1645-3 23471635
36. Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G, Duangchinda T, et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol. 2016;17(9):1102–8. doi: 10.1038/ni.3515 27339099
37. Mallewa M, Vallely P, Faragher B, Banda D, Klapper P, Mukaka M, et al. Viral CNS infections in children from a malaria-endemic area of Malawi: a prospective cohort study. Lancet Glob Health. 2013;1(3):e153–60. doi: 10.1016/S2214-109X(13)70060-3 24748325
38. Gourinat AC, O'Connor O, Calvez E, Goarant C, Dupont-Rouzeyrol M, Detection of Zika virus in urine. Emerg Infect Dis. 2014;21(1):84–6.
39. Paz-Bailey G, Rosenberg ES, Doyle K, Munoz-Jordan J, Santiago GA, Klein L, et al. Persistence of Zika Virus in Body Fluids—Preliminary Report. N Engl J Med. 2017.
40. Musso D, Teissier A, Rouault E, Teururai S, de Pina JJ, Nhan TX, Detection of chikungunya virus in saliva and urine. Virology journal. 2016;13:102. doi: 10.1186/s12985-016-0556-9 27306056